Answers are grounded in this paper and cite their sources.
Multicenter real-world study demonstrates the effect of insurance coverage on persistence with anti-CGRP therapy in Korea, suggesting a need for policy changes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: